CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
Windsor, Ontario, Canada and 85 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Farmington Hills, Michigan, United States of America and 155 other locations
study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...
Phase 4
Ann Arbor, Michigan, United States and 64 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Windsor, Ontario, Canada and 335 other locations
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...
Phase 2
Farmington Hills, Michigan, United States of America and 28 other locations
to therapy acting directly on the anti-IL-4R. This will be conducted by examining the effect of a 48 week therapy with dupilumab on the rate of asthma...
Phase 4
Detroit, Michigan, United States and 5 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Detroit, Michigan, United States and 140 other locations
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...
Phase 2
Dearborn, Michigan, United States and 59 other locations
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...
Phase 2
Windsor, Ontario, Canada and 78 other locations
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....
Phase 2
Detroit, Michigan, United States and 154 other locations
Clinical trials
Research sites
Resources
Legal